Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Mesalazine 1.2g gastro-resistant modified-release tablets |
| BNF code | 0105010B0AAARAR |
| Virtual Therapeutic Moiety | Mesalazine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Mesalazine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 1.200 |
| Strength value numerator unit | gram |
| Ontology Drug Form & Route | |
| Form & Route | tabletgastro-resistantmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Mezavant XL 1200mg tablets (CST Pharma Ltd) | |
| Mezavant XL 1200mg tablets (Lexon (UK) Ltd) | |
| Mezavant XL 1200mg tablets (Pilsco Ltd) | |
| Mezavant XL 1200mg tablets (Sigma Pharmaceuticals Plc) | |
| Mezavant XL 1200mg tablets (Takeda UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Mesalazine 1.2g gastro-resistant modified-release tablets 60 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.